Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Jecure Therapeutics logo — company profile

Jecure Therapeutics

Founded 2016 United States San Diego, United States 1 employees Series A Biotechnology, Health Care +1

General Information

Company Name Jecure Therapeutics
Founded Year 2016
Location United States San Diego, United States +1
Employees 1
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series A
Social

Get notified when Jecure Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Jecure Therapeutics

Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure’s academic founder is Dr. Ariel Feldstein, Division Chief of Gastroenterology at UCSD School of Medicine and a leading physician-scientist in hepatology. With operations in the biotech hub of San Diego, California, Jecure combines emerging NASH biology from Dr. Feldstein’s lab with an elite discovery team of veteran pharma/biotech scientists. Jecure’s lead program has identified small molecule inhibitors of a novel target and pro-inflammatory driver of NASH. Jecure is backed by top-tier life science investor Versant Ventures.

No funding data available for Jecure Therapeutics yet.

Get notified when Jecure Therapeutics raises funding

Jecure Therapeutics Alternatives & Competitors

Jecure Therapeutics vs
NorthSea Therapeutics
NorthSea Therapeutics The Netherlands

Clinical-stage biopharmaceutical company focused on the development of structurally engineered fatty...

Series C
16 employees
Biotechnology, Health Care
Jecure Therapeutics vs
Guardian Therapeutics Inc
Guardian Therapeutics Inc United States

Guardian is an independent, family- and employee-owned biotech enterprise specialized in discovery a...

Series Unknown
8 employees
Health and Wellness
Jecure Therapeutics vs
Ridgeline Discovery
Ridgeline Discovery Switzerland

A Versant Ventures Discovery Engine

60 employees
Biotechnology, IT

FAQ About Jecure Therapeutics

Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure’s academic founder is Dr. Ariel Feldstein, Division Chief of Gastroenterology at UCSD School of Medicine and a leading physician-scientist i...
Jecure Therapeutics was founded in 2016.
Jecure Therapeutics is headquartered in San Diego, United States.
Jecure Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Jecure Therapeutics has approximately 1 employees.
Top alternatives and competitors to Jecure Therapeutics include NorthSea Therapeutics, Guardian Therapeutics Inc, Ridgeline Discovery, Zhongze Therapeutics, Elgia Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Jecure Therapeutics and NorthSea Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Jecure Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy